Recent research from Stanford University and Harvard Medical School (both MA, USA) has used a combination of mouse models, human blood samples and statistical analysis to reveal the mechanism behind ...
RAMAT-GAN, Israel, Nov. 17, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases ...
Metformin showed promise for improving the overall survival rate of patients with melanoma; however, this result may be an indirect consequence of the drug. “Based on the progress of research on new ...
CHICAGO --- Millions of people take metformin, a Type 2 diabetes medication that lowers blood sugar. The “wonder drug” has also been shown to slow cancer growth, improve COVID outcomes and reduce ...
A new research paper was published in Aging (listed as "Aging (Albany NY)" by MEDLINE/PubMed and "Aging-US" by Web of Science) Volume 15, Issue 3, entitled, "Metformin use history and genome-wide DNA ...
Before the explosive popularity of GLP-1 weight loss drugs, another "wonder drug," metformin, has been at work lowering blood sugar levels for patients with Type 2 diabetes for decades, but scientists ...
The MarketWatch News Department was not involved in the creation of this content. -- The top-line results from the study showed that the 3-drugs' synergistic effect has the potential as a new ...
We are a biopharmaceutical company focused on the development of Aramchol. We have focused almost exclusively on developing Aramchol for the treatment of liver disease and we are currently seeking to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback